Literature DB >> 25660931

Ticagrelor crushed tablets administration in STEMI patients: the MOJITO study.

Guido Parodi, Ioanna Xanthopoulou, Benedetta Bellandi, Vassilios Gkizas, Renato Valenti, Stavros Karanikas, Angela Migliorini, Christos Angelidis, Rosanna Abbate, Sotirios Patsilinakos, Giorgio J Baldereschi, Rossella Marcucci, Gian Franco Gensini, David Antoniucci, Dimitrios Alexopoulos.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25660931     DOI： 10.1016/j.jacc.2014.08.056

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN： 0735-1097            Impact factor:   24.094


× No keyword cloud information.
  35 in total

Review 1.  Optimization of Antiplatelet Therapy in STEMI.

Authors:  Abhishek Sinha; Kush Agrawal; Rahul Sakhuja
Journal:  Curr Treat Options Cardiovasc Med       Date:  2017-08

2.  Crushed Versus Integral Tablets of Ticagrelor in ST-Segment Elevation Myocardial Infarction Patients: A Randomized Pharmacokinetic/Pharmacodynamic Study.

Authors:  Dimitrios Alexopoulos; Nikolaos Barampoutis; Vasileios Gkizas; Chrysoula Vogiatzi; Grigorios Tsigkas; Nikolaos Koutsogiannis; Periklis Davlouros; George Hahalis; Sven Nylander; Guido Parodi; Ioanna Xanthopoulou
Journal:  Clin Pharmacokinet       Date:  2016-03       Impact factor: 6.447

Review 3.  Contemporary management of ST-segment elevation myocardial infarction.

Authors:  Ajay Yadlapati; Mark Gajjar; Daniel R Schimmel; Mark J Ricciardi; James D Flaherty
Journal:  Intern Emerg Med       Date:  2016-10-06       Impact factor: 3.397

Review 4.  Risks of Opioids in ST-Elevation Myocardial Infarction: A Review.

Authors:  Anne Henrieke Tavenier; Renicus Suffridus Hermanides; Jan Paul Ottervanger; Peter Gerrit Johannes Ter Horst; Elvin Kedhi; Adriaan W J van 't Hof
Journal:  Drug Saf       Date:  2018-12       Impact factor: 5.606

Review 5.  Antiplatelet Therapy in Percutaneous Coronary Intervention.

Authors:  Alexander C Fanaroff; Sunil V Rao
Journal:  Interv Cardiol Clin       Date:  2016-02-13

Review 6.  Antithrombotic therapy for patients with STEMI undergoing primary PCI.

Authors:  Francesco Franchi; Fabiana Rollini; Dominick J Angiolillo
Journal:  Nat Rev Cardiol       Date:  2017-02-23       Impact factor: 32.419

7.  Pre-hospital treatment of patients with acute coronary syndrome: Recommendations for medical emergency teams. Expert position update 2022.

Authors:  Jacek Kubica; Piotr Adamski; Jerzy R Ładny; Jarosław Kaźmierczak; Tomasz Fabiszak; Krzysztof J Filipiak; Robert Gajda; Mariusz Gąsior; Zbigniew Gąsior; Robert Gil; Jarosław Gorący; Stefan Grajek; Leszek Gromadziński; Marcin Gruchała; Grzegorz Grześk; Piotr Hoffman; Miłosz J Jaguszewski; Marianna Janion; Piotr Jankowski; Zbigniew Kalarus; Jarosław D Kasprzak; Andrzej Kleinrok; Wacław Kochman; Aldona Kubica; Wiktor Kuliczkowski; Jacek Legutko; Maciej Lesiak; Klaudiusz Nadolny; Eliano P Navarese; Piotr Niezgoda; Małgorzata Ostrowska; Przemysław Paciorek; Jolanta Siller-Matula; Łukasz Szarpak; Dariusz Timler; Adam Witkowski; Wojciech Wojakowski; Andrzej Wysokiński; Marzenna Zielińska
Journal:  Cardiol J       Date:  2022-05-06       Impact factor: 3.487

8.  Facilitation Through Aggrastat or Cangrelor Bolus and Infusion Over PrasugreL: a MUlticenter Randomized Open-label Trial in PatientS with ST-elevation Myocardial InFarction Referred for PrimAry PercutaneouS InTERvention (FABOLUS FASTER) Trial: Design and Rationale : The FABOLUS FASTER Trial.

Authors:  Giuseppe Gargiulo; Giovanni Esposito; Plinio Cirillo; Michael Nagler; Pietro Minuz; Gianluca Campo; Felice Gragnano; Negar Manavifar; Raffaele Piccolo; Marisa Avvedimento; Matteo Tebaldi; Andreas Wahl; Lukas Hunziker; Michael Billinger; Dik Heg; Stephan Windecker; Marco Valgimigli
Journal:  J Cardiovasc Transl Res       Date:  2020-02-24       Impact factor: 4.132

9.  Effect of Chewing vs Swallowing Ticagrelor on Platelet Inhibition in Patients With ST-Segment Elevation Myocardial Infarction: A Randomized Clinical Trial.

Authors:  Elad Asher; Shir Tal; Israel Mazin; Arsalan Abu-Much; Avi Sabbag; Moshe Katz; Ehud Regev; Fernando Chernomordik; Victor Guetta; Amit Segev; Dan Elian; Israel Barbash; Paul Fefer; Michael Narodistky; Roy Beigel; Shlomi Matetzky
Journal:  JAMA Cardiol       Date:  2017-12-01       Impact factor: 14.676

10.  Pharmacokinetics, pharmacodynamics, and tolerability of subcutaneous administration of a novel glycoprotein IIb/IIIa inhibitor, RUC-4, in patients with ST-segment elevation myocardial infarction.

Authors:  Willem L Bor; Kai L Zheng; Anne H Tavenier; C Michael Gibson; Christopher B Granger; Ohad Bentur; Rita Lobatto; Sonja Postma; Barry S Coller; Arnoud W J van 't Hof; Jurrien M Ten Berg
Journal:  EuroIntervention       Date:  2021-08-06       Impact factor: 7.728
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.